16/08/2023
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
August 2023
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Sep »
16/08/2023
Aug 16, 2023, 18:30 |
Insight
Sangeetha Reddy: Dendritic cell therapy augments anti-tumor immunity with CDK4/6i and immune checkpoint blockade!
Quoting Sangeetha Reddy, Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center,…
Aug 16, 2023, 18:22 |
Opinion
Anas Younes: Interesting report, although I disagree with some of the comments.
In a LinkedIn post, Anas Younes, Senior VP, Global Head of Hematology (Early and Late…
Aug 16, 2023, 18:20 |
Opinion
James Coyne: The article provides a summary of my thinking about a seriously flawed study that gave false hope to breast cancer patients.
Quoting from a recent LinkedIn post by James Coyne, Emeritus Professor of Psychology in Psychiatry…
Aug 16, 2023, 18:18 |
Blog
Roupen Odabashian: Three Important Things They Don't Teach in Medical School.
In a LinkedIn post, Roupen Odabashian, Hematology/Oncology Fellow at the Karmanos Cancer Institute, wrote: ''Three…
Aug 16, 2023, 18:14 |
Blog
Kevin Neilson: I was photographing Dr. Vinay Prasad. Be sure to capture his heroic visage.
In a LinkedIn post, Kevin Neilson, writer and photographer, states: ''When I told family and…
Aug 16, 2023, 14:28 |
Blog
Allison Hopkins: Come work with the amazing Meetings team at American Society of Clinical Oncology (ASCO)
Allison Hopkins, Division Director at American Society of Clinical Oncology, shared a wonderful opportunity on her…
Aug 16, 2023, 14:15 |
Blog
Rebecca Love: Thank you to Becker's Healthcare for including me in this conversation by healthcare leaders on the State of nursing.
Rebecca Love, Chief Clinical Officer at IntelyCare, stated the following in her LinkedIn post: "Thank…
Aug 16, 2023, 13:39 |
Opinion
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani: The idea that early use of parp inhibitors would be beneficial, while late use would be harmful, lacks plausibility and a reasonable explanation.
Aug 16, 2023, 13:28 |
Opinion
Dr. Roupen Odabashian: Being organized is something I strive for every day!
In a LinkedIn post, Dr. Roupen Odabashian, Hematology/Oncology Fellow at the Karmanos Cancer Institute, shared…
Aug 16, 2023, 13:02 |
Blog
Sendurai Mani: The Legorreta Cancer Center at Brown University, Dr. Wafik S. El-Deiry, MD, and I cordially invite all to participate in the forthcoming symposium on Tumor Plasticity in Diagnosis and Treatment.
1
2
3
4
All:
31
Posts:
21 - 30
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube